|Biotech Due Diligence||
Head over to the Pipelines page for a compilation of the latest data on the research and development pipelines highlighting the drugs and biologics in clinical development from about 20 of the largest biotech and pharmaceuticals companies on the planet. Most of these companies provided new updates as of July or August 2015 which I have captured, along with the historical information when possible.
Weary of endless chatter about Martin Shkreli, Turing Pharma, and pharmaceutical drug pricing? Then enjoy a fresh installment of the Biotech Reading List instead!
Perhaps there was no defining storyline, but biotech newsflow and discussion were in full Fall / investor conference season mode this week. Catch up on all the highlights in the most recent edition of the Biotech Tweets of the Week, curated by @23aloha and @BioDueDiligence.
$ADXS $AERI $AQXP $BLUE $CEMP $ESPR $FMI $FOLD $GILD $ITCI $LLY $NBIX $QURE $RPTP $SRPT $TGTX $VRTX $XNPT $XBI $IBB
If you're sick of reading about the nonexistent Federal Reserve rate hike, enjoy another round of the BiotechDueDiligence Journal Watch, featuring papers highlighted by some of the best and brightest on the Biotech Twitter stream.
Your support is greatly appreciated